Jefferies Starts Novavax (NVAX) at Buy, $200 PT; Set to Become Major COVID-19 Vaccine Player

Go back to Jefferies Starts Novavax (NVAX) at Buy, $200 PT; Set to Become Major COVID-19 Vaccine Player
Novavax, Inc. (NASDAQ: NVAX) Delayed: 8.05 -0.09 (1.11%)
Previous Close $8.14    52 Week High $9.23 
Open $8.13    52 Week Low $1.16 
Day High $8.13    P/E N/A 
Day Low $7.92    EPS $-0.30 
Volume 2,279,572